EBAMed

Geneve, Switzerland Founded: 2018 • Age: 8 yrs
Non-invasive treatments for cardiac arrhythmias are developed by EBAMed.
Request Access

About EBAMed

EBAMed is a company based in Geneve (Switzerland) founded in 2018.. EBAMed has raised $18.64 million across 8 funding rounds from investors including Mayo Clinic, European Union and Liftt. EBAMed offers products and services including External Beam Ablation Devices. EBAMed operates in a competitive market with competitors including AtaCor Medical, AtriCure, Kestra Medical Technologies, CardioFocus and TyRx, among others.

  • Headquarter Geneve, Switzerland
  • Sectors
    Media & Entertainment
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Ebamed Sa
Operational Areas
Media & Entertainment → Creative & Content Production
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $18.64 M (USD)

    in 8 rounds

  • Latest Funding Round
    $1.67 M (USD), Series A

    Jan 25, 2024

  • Investors
    Mayo Clinic

    & 8 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of EBAMed

EBAMed offers a comprehensive portfolio of products and services, including External Beam Ablation Devices. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Tools for non-invasive radio-therapy treatment of heart arrhythmias

People of EBAMed
Headcount 1-10
Employee Profiles 7
Employee Profiles
People
Chiara Bonacini
Corporate Affairs And Finance Controller
People
Marina Izzo
CEO
People
Adriano Garonna
Chief Technology Officer
People
Barbara Castellano
Director

Unlock access to complete

Funding Insights of EBAMed

EBAMed has successfully raised a total of $18.64M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $1.67 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 8
  • Last Round Series A — $1.7M
  • First Round

    (01 Aug 2019)

  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2024 Amount Series A - EBAMed Valuation

investors

Jun, 2023 Amount Series A - EBAMed Valuation Panakes Partners
Sep, 2022 Amount Seed - EBAMed Valuation Fongit
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in EBAMed

EBAMed has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Mayo Clinic, European Union and Liftt. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital and fund of funds focused on multiple sectors
Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by EBAMed

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - EBAMed

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ebamed Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of EBAMed

EBAMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtaCor Medical, AtriCure, Kestra Medical Technologies, CardioFocus and TyRx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
An implantable pacemaker system is developed for cardiac pacing therapy.
domain founded_year HQ Location
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
domain founded_year HQ Location
Medical devices are developed to support cardiovascular patients at risk.
domain founded_year HQ Location
Endoscopic catheter for atrial fibrillation ablation is developed.
domain founded_year HQ Location
Antibacterial envelopes are developed for stabilizing cardiac implantable devices.
domain founded_year HQ Location
Wireless cardiac pacing devices are developed for left ventricle stimulation.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ebamed

Frequently Asked Questions about EBAMed

When was EBAMed founded?

EBAMed was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Where is EBAMed located?

EBAMed is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.

Is EBAMed a funded company?

EBAMed is a funded company, having raised a total of $18.64M across 8 funding rounds to date. The company's 1st funding round was a Seed of $100.97K, raised on Aug 01, 2019.

What does EBAMed do?

EBAMed was founded in 2018 in Geneva, Switzerland, as a medical device company in the healthcare sector. Innovative solutions for non-invasive and automated treatment of heart arrhythmias are developed, incorporating technologies such as proton therapy. Efficient options for patients are targeted through these products. Significant funding has been secured to support technology advancement and product expansion. Operations focus on improving treatment outcomes in cardiac care.

Who are the top competitors of EBAMed?

EBAMed's top competitors include AtaCor Medical, AtriCure and CardioFocus.

What products or services does EBAMed offer?

EBAMed offers External Beam Ablation Devices.

Who are EBAMed's investors?

EBAMed has 9 investors. Key investors include Mayo Clinic, European Union, Liftt, CDP Venture Capital, and Panakes Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available